katie8288Feb 7, 20220 min readuniQure Announces Dosing of First Patients in Europe Open-Label Trial of AMT-130
Wave received supportive initial feedback from FDA on WVE-003. FDA also granted WVE-003 Orphan Drug Designation.
Comments